These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 32660924)

  • 1. Bivalirudin for Maintenance Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation for COVID-19.
    Seelhammer TG; Rowse P; Yalamuri S
    J Cardiothorac Vasc Anesth; 2021 Apr; 35(4):1149-1153. PubMed ID: 32660924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin.
    Rivosecchi RM; Arakelians AR; Ryan J; Murray H; Ramanan R; Gomez H; Phillips D; Sciortino C; Arlia P; Freeman D; Sappington PL; Sanchez PG
    Crit Care Med; 2021 Jul; 49(7):1129-1136. PubMed ID: 33711003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bivalirudin for Alternative Anticoagulation in Extracorporeal Membrane Oxygenation: A Systematic Review.
    Sanfilippo F; Asmussen S; Maybauer DM; Santonocito C; Fraser JF; Erdoes G; Maybauer MO
    J Intensive Care Med; 2017 Jun; 32(5):312-319. PubMed ID: 27356945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study.
    Pieri M; Agracheva N; Bonaveglio E; Greco T; De Bonis M; Covello RD; Zangrillo A; Pappalardo F
    J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):30-4. PubMed ID: 23036625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation Management in Severe Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation.
    Guo Z; Sun L; Li B; Tian R; Zhang X; Zhang Z; Clifford SP; Liu Y; Huang J; Li X
    J Cardiothorac Vasc Anesth; 2021 Feb; 35(2):389-397. PubMed ID: 32994131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Bivalirudin as the Primary Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation for SARS-CoV-2-Associated Acute Respiratory Failure.
    Bissell BD; Gabbard T; Sheridan EA; Baz MA; Davis GA; Ather A
    Ann Pharmacother; 2022 Apr; 56(4):387-392. PubMed ID: 34323121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bivalirudin in venovenous extracorporeal membrane oxygenation.
    Jyoti A; Maheshwari A; Daniel E; Motihar A; Bhathiwal RS; Sharma D
    J Extra Corpor Technol; 2014 Mar; 46(1):94-7. PubMed ID: 24779126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma exchange on venovenous extracorporeal membrane oxygenation with bivalirudin anticoagulation.
    Preston TJ; Dalton HJ; Nicol KK; Ferrall BR; Miller JC; Hayes D
    World J Pediatr Congenit Heart Surg; 2015 Jan; 6(1):119-22. PubMed ID: 25548358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Systemic Heparin Versus Bivalirudin in Adult Patients Supported by Extracorporeal Membrane Oxygenation.
    Berei TJ; Lillyblad MP; Wilson KJ; Garberich RF; Hryniewicz KM
    ASAIO J; 2018; 64(5):623-629. PubMed ID: 29076942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation.
    Kaseer H; Soto-Arenall M; Sanghavi D; Moss J; Ratzlaff R; Pham S; Guru P
    J Card Surg; 2020 Apr; 35(4):779-786. PubMed ID: 32048330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Description of Bivalirudin Use for Anticoagulation in Pediatric Patients on Mechanical Circulatory Support.
    Campbell CT; Diaz L; Kelly B
    Ann Pharmacother; 2021 Jan; 55(1):59-64. PubMed ID: 32590908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Bivalirudin for Therapeutic Anticoagulation in COVID-19 Patients Requiring ECMO Support.
    Trigonis R; Smith N; Porter S; Anderson E; Jennings M; Kapoor R; Hage C; Moiz S; Garcia J; Rahman O
    J Cardiothorac Vasc Anesth; 2022 Feb; 36(2):414-418. PubMed ID: 34782234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy.
    Macielak S; Burcham P; Whitson B; Abdel-Rasoul M; Rozycki A
    Perfusion; 2019 Nov; 34(8):671-678. PubMed ID: 31057056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bivalirudin in pediatric patients maintained on extracorporeal life support.
    Nagle EL; Dager WE; Duby JJ; Roberts AJ; Kenny LE; Murthy MS; Pretzlaff RK
    Pediatr Crit Care Med; 2013 May; 14(4):e182-8. PubMed ID: 23648880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bivalirudin resistance in a patient on veno-venous extracorporeal membrane oxygenation with a therapeutic response to argatroban.
    Berlioz B; Kaseer HS; Sanghavi DK; Guru PK
    BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31915185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is anticoagulation with bivalirudin comparable to heparin for pediatric extracorporeal life support? Results from a high-volume center.
    Schill MR; Douds MT; Burns EL; Lahart MA; Said AS; Abarbanell AM
    Artif Organs; 2021 Jan; 45(1):15-21. PubMed ID: 32557733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Bivalirudin Versus Unfractionated Heparin for Anticoagulation in Adult Patients on Extracorporeal Membrane Oxygenation.
    Sheridan EA; Sekela ME; Pandya KA; Schadler A; Ather A
    ASAIO J; 2022 Jul; 68(7):920-924. PubMed ID: 34669620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Thrombin Inhibition in Extracorporeal Membrane Oxygenation.
    Geli J; Capoccia M; Maybauer DM; Maybauer MO
    Int J Artif Organs; 2022 Jul; 45(7):652-655. PubMed ID: 35411823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of bivalirudin for anticoagulation in pediatric extracorporeal membrane oxygenation (ECMO).
    Kaushik S; Derespina KR; Chandhoke S; Shah DD; Cohen T; Shlomovich M; Medar SS; Peek GJ
    Perfusion; 2023 Jan; 38(1):58-65. PubMed ID: 34318718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Wholesale Drug Acquisition and Laboratory Assessment Costs Between Heparin Compared With Bivalirudin-Based Systemic Anticoagulation Strategies in Adult Extracorporeal Membrane Oxygenation.
    Seelhammer TG; Brokmeier HM; Hamzah M; Wieruszewski PM
    Crit Care Med; 2023 May; 51(5):e115-e121. PubMed ID: 36853326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.